Literature DB >> 1498403

Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole.

F Baudraz-Rosselet1, M Monod, L Borradori, J M Ginalsky, B Vion, C Boccard, E Frenk.   

Abstract

We report the case of a 30-year-old Nigerian patient with mycetoma of the foot without bone involvement caused by Fusarium sp..Long-term administration of ketoconazole produced a significant improvement with good clinical and biological tolerance.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1498403     DOI： 10.1159/000247578

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  6 in total

1.  A case of primary localized cutaneous infection due to Fusarium oxysporum.

Authors:  C Romano; P Caposciutti; A Ghilardi; C Miracco; M Fimiani
Journal:  Mycopathologia       Date:  2010-02-24       Impact factor: 2.574

Review 2.  Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing.

Authors:  H Yera; M E Bougnoux; C Jeanrot; M T Baixench; G De Pinieux; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Mycetoma caused by Fusarium solani with osteolytic lesions on the hand: case report.

Authors:  Jane Tomimori-Yamashita; Marília M Ogawa; Sérgio H Hirata; Olga Fischman; Nílceo S Michalany; Hélio Kiitiro Yamashita; Mauricio Alchorne
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

Review 4.  Taxonomy, biology, and clinical aspects of Fusarium species.

Authors:  P E Nelson; M C Dignani; E J Anaissie
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 5.  Opportunistic fusarial infections in humans.

Authors:  J Guarro; J Gené
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

6.  Fusarium solani causing quasi-invasive infection of the foot in an immunocompetent middle-aged man from South India.

Authors:  Mohan H Kudur; Py Prakash; M Savitha
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.